Fei Jie

Fei Jie is a seasoned biostatistics professional with extensive experience in the pharmaceutical industry. Currently serving as Senior Director of Biostatistics at Pfizer since December 2023, Fei Jie leads a team in statistical initiatives. Previously, as Senior Director at Seagen from January 2022 to December 2023, Fei Jie was the global statistical lead for Adcetris, contributing to its approval for pediatric patients with untreated high-risk classical Hodgkin lymphoma. Fei Jie also held the position of Director of Biostatistics at Daiichi Sankyo, overseeing statistical support for Enhertu in breast cancer, and has significant experience with Astellas Pharma as Biostatistics Director, focusing on solid tumors and hematological malignancies. Earlier experience includes working as a Statistician at AbbVie in late-stage oncology development. Fei Jie holds a Ph.D. in Biostatistics from the University of Illinois Chicago and a Ph.D. in Immunology from Iowa State University.